Medical University of South Carolina, Revival Healthcare Capital to Collaborate on Medical Technologies

The Medical University of South Carolina (MUSC) is teaming up with Revival Healthcare Capital to accelerate the evaluation, development and clinical advancement of next-generation medical technologies.

Under the five-year agreement, MUSC and Revival will establish a scalable collaboration model that enables rapid activation of project-specific initiatives.

“This collaboration reflects MUSC’s commitment to advancing innovation that improves patient care and health outcomes,” MUSC President David J. Cole, M.D., said. “By working closely with Revival Healthcare Capital, our clinicians and researchers can help evaluate and inform the development of promising medical technologies, strengthening the pathway from clinical insight to real‑world impact.”

As part of the collaboration, MUSC clinicians and subject-matter experts may provide clinical and procedural insights to inform the evaluation of technologies aligned with Revival’s investment strategy. In addition, MUSC leaders may serve as advisors to Revival portfolio companies, providing clinical and health system validation to help accelerate the product development lifecycle.

MUSC’s innovation ecosystem is focused on translating scientific discovery and clinical insight into scalable solutions. This partnership with Revival is intended to complement MUSC’s innovation mission by creating a clearer pathway for capital, operational expertise and industry alignment.

The collaboration also creates a pathway for Revival to evaluate select MUSC-originated medical device opportunities. Revival’s investment approach and partners could support later-stage clinical development and the advancement of medical device innovation.

“We are pleased to partner with MUSC to create a repeatable, high-velocity collaboration model that supports our investment strategy and our portfolio companies,” stated Todd M. Pope, senior partner at Revival Healthcare Capital. “By combining Revival’s flexible capital model and operational capabilities with MUSC’s strong collaboration across patient care, research, and education, we believe this partnership can advance technologies that address unmet patient needs.”

Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a mission to preserve and optimize human life through education, research, and patient care. Each year, MUSC educates nearly 3,500 students in six colleges and trains more than 1,060 residents and fellows across its health system. MUSC leads the state in federal, National Institutes of Health, and other research funding.

As the healthcare system of the Medical University of South Carolina, MUSC Health delivers patient care while educating and training generations of healthcare providers and leaders. In 2025, U.S. News & World Report named MUSC Health University Medical Center in Charleston the No. 1 hospital in South Carolina for the 11th consecutive year.

Revival Healthcare Capital is an investment firm focused on the medtech sector. Revival specializes in transformative external innovation partnerships and other opportunities where its team of experienced operators and investors believes it can provide leadership, resources, and deep sector insights—beyond its capital—to further support companies’ growth strategies.